Update search
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Journal
Type
Date
Availability
1-3 of 3
Keywords: Buprenorphine
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Journal:
Drugs and Alcohol Today
Drugs and Alcohol Today (2018) 18 (4): 206–216.
Published: 18 May 2018
... in employment. Edward Day can be contacted at: edward.day@kcl.ac.uk 04 12 2017 12 01 2018 28 01 2018 © Emerald Publishing Limited 2018 Emerald Publishing Limited Licensed re-use rights only Employment Recovery Quality of life Methadone Buprenorphine Opioid-related...
Journal Articles
Journal:
Drugs and Alcohol Today
Drugs and Alcohol Today (2016) 16 (4): 259–266.
Published: 05 December 2016
...David Kingsley Payler Purpose The purpose of this paper is to examine whether it is possible to switch patients from heroin or methadone to buprenorphine without needing to experience symptoms of withdrawal? Design/methodology/approach Review of author’s experience in 1980s where three...
Journal Articles
Journal:
Drugs and Alcohol Today
Drugs and Alcohol Today (2014) 14 (3): 114–125.
Published: 26 August 2014
... for 44, 34 and 23 per cent of patients receiving methadone, mono-buprenorphine and buprenorphine-naloxone, respectively. Practical implications – Interruptions to opioid dependence treatment in various forms can hamper the recovery of opioid-dependent patients. The benefits of MAT may not be fully...
